T 0524/01 (Recombinant influenza virus/MEDIMMUNE) of 21.10.2005

European Case Law Identifier: ECLI:EP:BA:2005:T052401.20051021
Date of decision: 21 October 2005
Case number: T 0524/01
Application number: 90913914.9
IPC class: C12N 15/11
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 112 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Recombinant negative strand RNA virus expression systems and vaccines
Applicant name: MEDIMMUNE VACCINES, INC.
Opponent name: American Cyanamid Company
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 84
European Patent Convention 1973 Art 111(1)
European Patent Convention 1973 Art 114(2)
European Patent Convention 1973 Art 123
European Patent Convention 1973 R 57a
Keywords: Main and first auxiliary request - sufficiency of disclosure (no)
Second auxiliary request - not allowed
No further requests allowed into the proceedings
Catchwords:

-

Cited decisions:
T 0409/91
T 0435/91
T 0322/93
T 0794/94
T 0113/96
T 0950/99
T 0716/01
Citing decisions:
T 0821/09

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010524eu1.html

Date retrieved: 17 May 2021

8 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: II Conditions to be met by an Application

General Case Law